Cerebral Vasospasm: Advances in Research and Treatment Book

1	Signaling pathways in cerebral vasospasm	3
2	A new approach to the mechanism of smooth muscle contraction : calmodulin sensor MLC kinase mice	8
3	Changes in vascular ion channels after experimental subarachnoid hemorrhage	12
4	Inhibition of src tyrosine kinase reduces experimental cerebral vasospasm	17
5	Potassium channels in experimental cerebral vasospasm	20
6	Sphingosine-1-phosphate-induced arterial contraction and Ca[superscript 2+] sensitization	25
7	Potential role of potassium channels in tyrosine kinase inhibitor-induced vascular relaxation in rat basilar artery : a patch-clamp study	29
8	The role of calcium-activated potassium channels in the mouse model of chronic cerebral vasospasm	32
9	Protein kinase C isoforms, rho kinase, and myosin light chain phosphorylation as mechanisms of cerebral vasospasm after subarachnoid hemorrhage	36
10	Magnesium in subarachnoid hemorrhage : is it that simple?	43
11	Pathogenesis of cerebral vasospasm : the role of cerebral microcirculatory changes	47
12	Bilirubin oxidation products and their possible role in subarachnoid hemorrhage-induced cerebral vasospasm	51
13	Activation of microglia after experimental subarachnoid hemorrhage in rats	57
14	Smooth muscle phenotype change in canine basilar artery after experimental subarachnoid hemorrhage	62
15	Inflammation and cerebral vasospasm : new perspectives	65
16	Pathophysiology of delayed vasospasm after SAH : new hypothesis and implications for treatment	71
17	Endothelin B receptor null mutation prevents subarachnoid hemorrhage-induced cerebral vasospasm in the rat in vivo	75
18	Experimental SAH alters endothelin receptor pheonotype in rat cerebral arteries	79
19	Endothelial dysfunction in a primate model of cerebral vasospasm	83
20	Increased contractile effect of endothelin-1 on isolated rat basilar artery after experimental subarachnoid hemorrhage	86
21	CSF levels of ADMA, an endogenous inhibitor of nitric oxide synthase, are associated with vasospasm after subarachnoid hemorrhage	90
22	Monitoring activation of the cerebral endothelin system after subarachnoid hemorrhage by measuring C-terminal fragment in cerebrospinal fluid	93
23	Cytokines produce apoptosis in cultured cerebral endothelial cells	97
24	Controversial issues regarding the pathophysiology of vasospasm : a review	103
25	Cerebral vasospasm revisited : SAH syndrome	106
26	Intravascular adenoviral gene transfection of monkey cerebral arteries using micro-balloon catheters	112
27	Oxyhemoglobin potentiation of thromboxane A[subscript 2]-induced contraction of porcine basilar arteries	116
28	Cytosolic calcium oscillations induced by cisternal cerebrospinal fluid from SAH patients	119
29	Nicotine exposure potentiates vasoconstriction of canine basilar artery via protein kinase C activation and attenuation of nitric oxide synthesis	122
30	Experimental SAH upregulates 5-HT[subscript 1B] receptors in rat cerebral arteries	126
31	What is the key factor expressed in human spastic arteries after SAH?	129
32	Expression of hypoxia inducible factor-1 in a rat subarachnoid hemorrhage model	134
33	Interactive role of protein kinase C isoforms and Rho kinase in vasospasm after experimental subarachnoid hemorrhage	138
34	Possible role of heme oxygenase-1 and ferritin in cerebral vasospasm after aneurysmal subarachnoid hemorrhage	142
35	Hypothermia reduces metabolic alterations caused by acute vasospasm after SAH in rats : a microdialysis and magnetic resonance spectroscopy study	146
36	Prevention of experimental cerebral vasospasm by intrathecal delivery of liposomal fasudil	153
37	Magnesium and cerebral vasospasm	156
38	Phosphodiesterase III inhibitor for the treatment of chronic cerebral vasospasm in dogs	160
39	Intraoperative microvascular Doppler sonography for monitoring vasospasm and use of topical vasodilators during intracranial aneurysm surgery	167
40	Basilar vasospasm following aneurysmal subarachnoid hemorrhage : TCD and SPECT correlation	171
41	Comparison of positron emission tomography cerebral perfusion with transcranial Doppler in subarachnoid hemorrhage patients with neurological deterioration	174
42	Brain perfusion computed tomography in severe symptomatic vasospasm	177
43	Vasospasm and regional brain perfusion : correlation between TCD and CT perfusion measurement	180
44	Regional cerebral blood flow monitoring for the diagnosis of delayed ischemia after aneurysmal subarachnoid hemorrhage	183
45	Sex and clinical cerebral vasospasm in Yorkshire, UK
46	Factors influencing vasospasm after aneurysmal subarachnoid hemorrhage : a prospective observational study in the north of England	194
47	Grading scale for subarachnoid hemorrhage based on a modification of the World Federation of Neurological Surgeons scale	197
48	Effect of inotrope-induced blood pressure changes on cerebral perfusion in patients with subarachnoid hemorrhage : a positron emission tomography study	201
49	The role of isoprostane in vasospasm after aneurysmal subarachnoid hemorrhage in humans : preliminary experience	204
50	S-100B and neuron specific enolase as predictors of cerebral vasospasm and infarcts after subarachnoid hemorrhage	208
51	The APACHE score for early detection of cerebral vasospasm	212
52	Sequential changes in oxyhemoglobin in fluid drained from SAH patients undergoing cisternal irrigation	216
53	Sex and racial factors in the outcome of subarachnoid hemorrhage in Mississippi	220
54	Clinical trial dilemmas in vasospasm	227
55	Circulating blood volume after subarachnoid hemorrhage	231
56	Cerebrovascular effects of hypertonic saline in poor grade patients with subarachnoid hemorrhage	234
57	Panax notoginseng saponins for prevention of vasospasm and delayed ischemic neurological deficits after SAH : a review	236
58	Effect of hydrocortisone on excess natriuresis in patients with aneurysmal subarachnoid hemorrhage	240
59	Safety and efficacy of the different components of hemodynamic therapy in patients with symptomatic vasospasm	243
60	Symptomatic vasospasm after early surgical and endovascular treatment of ruptured cerebral aneurysms	249
61	Endovascular treatment for cerebral vasospasm	252
62	CSF drainage for prevention and reversal of cerebral vasospasm after surgical treatment of intracranial aneurysms	255
63	Cerebral vasospasm is markedly reduced by lumbar cerebrospinal fluid drainage	259
64	Fenestration of the lamina terminalis reduces vasospasm after subarachnoid hemorrhage from anterior communicating artery aneurysms	263